[Cosmos Pharmaceuticals] Board of Directors Re-elects Mr. Sheng Bao-Hsi as Chairman
Key facts
- [Cosmos Pharmaceuticals] Board of Directors Re-elects Mr. Sheng Bao-Hsi as Chairman
- Cosmos Pharmaceuticals' Board of Directors resolved on June 9, 115 (2026) to re-elect Mr. Sheng Bao-Hsi as Chairman following the expiration of his term. This is a routine re-election and is not expected to have a significant impact on shareholder rights or stock prices.
- Source: PR Times
- Date: June 9, 2026
Direct answer
Cosmos Pharmaceuticals' Board of Directors resolved on June 9, 115 (2026) to re-elect Mr. Sheng Bao-Hsi as Chairman following the expiration of his term. This is a routine re-election and is not expected to have a significant impact on shareholder rights or stock prices.
- Citation
- [Cosmos Pharmaceuticals] Board of Directors Re-elects Mr. Sheng Bao-Hsi as Chairman (June 9, 2026), PR Times
- Source
- PR Times
- Date
- June 9, 2026
Cosmos Pharmaceuticals' Board of Directors resolved on June 9, 115 (2026) to re-elect Mr. Sheng Bao-Hsi as Chairman following the expiration of his term. This is a routine re-election and is not expected to have a significant impact on shareholder rights or stock prices.
📋 Article Processing Timeline
- 📰 Published: June 9, 2026 at 09:00
- 🔍 Collected: June 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 17:53 (57h 53m after Collected)
2. Personnel Category (Please enter Chairman or General Manager): Chairman
3. Former Incumbent's Name: Sheng Bao-Hsi.
4. Former Incumbent's Biography: Sheng Bao-Hsi, Chairman of the Company.
5. New Appointee's Name: Sheng Bao-Hsi.
6. New Appointee's Biography: Sheng Bao-Hsi, Chairman of the Company.
7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Job Adjustment', 'Redundancy', 'Retirement', 'Death', or 'New Appointment'): Term Expiration
8. Reason for Change: Re-election due to term expiration.
9. Effective Date of New Appointment: 115/06/09
10. Other Matters to be Noted (If the subject of the event or resolution is a publicly issued company or above, this major information also meets the criteria of Article 7, Paragraph 6 of the Regulations Governing the Tender Offer for Securities of Public Companies, which has a material impact on shareholder rights or securities prices): None
Keywords: Major Information
FAQ
Who is the Chairman of Cosmos Pharmaceuticals?
The Chairman of Cosmos Pharmaceuticals is Mr. Sheng Bao-Hsi. He has been re-elected as Chairman following the expiration of his term.
When was this personnel change announced?
The board resolution regarding the re-election of Chairman Sheng Bao-Hsi was made on June 9, 115 (2026).
How will Mr. Sheng Bao-Hsi's re-election affect Cosmos Pharmaceuticals' management?
The re-appointment of the current Chairman suggests continuity in management policies, with expectations for business development under a stable management foundation.
What kind of business does Cosmos Pharmaceuticals conduct?
Cosmos Pharmaceuticals is engaged in the research, development, manufacturing, and sales of pharmaceuticals and medical devices, contributing to the improvement of people's health and quality of life.
Is this news important for investors?
Leadership stability can be a reassuring factor for investors, but this news itself is a routine personnel change and is considered to have a limited direct impact on stock prices.